= Abstract = Cytomegalovirus (CMV) is one of the most commonly encountered viral pathogens in newborn infants and is found in 0.3-2.4% of all live births. It has been demonstrated that 40-96% of seropositive mothers shed the virus via their breast milk. Breast milk containing CMV can cause almost one-third of CMV infections occurring in infants. A case of postnatal CMV infection in an extremely premature infant (gestational age 24 +5 weeks, birth weight 750 g) transmitted via breast milk is presented. For neonatal intensive care unit (NICU) management of severe thrombocytopenia, anemia, and sepsis syndrome, the infant received repeated transfusions of platelets; intravenous (IV) immunoglobulins; and gammairradiated, filtrated packed red cells and was fed her mother's breast milk since the second week of life. CMV infection was diagnosed with positive CMV immunoglobulin M (IgM) and positive urine CMV culture at the second month of life. Considering the negative CMV IgM and urine CMV culture at birth, postnatally-acquired CMV infection was suspected and confirmed with completely identical nucleotide sequence alignments of the infantile blood isolate and the maternal breast milk isolate. To our knowledge, this is the first case of proven postnatal CMV infection transmitted via breast milk in an extremely premature infant in Korea. (Korean J Pediatr 2009;52:1053-1058 
Introduction
Cytomegalovirus (CMV) is the most common cause of intrauterine and perinatal infections worldwide 1) . CMV can be transmitted in three distinct modes; transplacentally (congenital CMV) or through ingestion of infected body fluids such as maternal genital secretions during the intrapartum (perinatal CMV), or through ingestion of infected breast milk (postnatal CMV) 2) . Acquisition of CMV through breast milk has been identified as the most important route of postnatal transmission 3, 4) . Transmission of CMV to infants who have been fed with CMV-positive breast milk had been reported to be as high as 38-70% 5, 6) . Ap-proximately 87 percent of women are reported to have CMV antibodies by child bearing age in South Korea 7) . In another study, 96 percent of pregnant women had CMV antibodies by the end of the third trimester 8) . Postnatal CMV infection via breast milk in a community with such high prevalence of maternal CMV immunity as South Korea would be an important issue in determining the best feeding practices for very low birth weight infants. We report a case of an extremely low birth weight infant in whom, by nucleotide sequencing, CMV infection was confirmed to have been acquired through maternal breast milk.
Case Report
A 31-year-old gravida 1 para 0 woman was referred to the emergency department due to preterm premature rupture of membranes and threatened labor. After admission, an extremely low birth weight female infant (750 g) was delivered at 24 +5 weeks of gestation by Cesarean section. The infant had Apgar scores of one at 1 minute Fig. 1 . Human CMV gB gene amplification products were detected from maternal blood, urine, breast milk, infantile blood, urine, and the CMV laboratory-adapted strains, Towne, and AD 169. and 3 at 5 minutes. Her general appearance was lethargic and cyanotic without spontaneous respiratory effort. Morphologic features showed no abnormalities except a single umbilical artery. Soon after delivery, the baby was intubated. The infant required resuscitation and was immediately transferred to the neonatal intensive care unit. Her laboratory tests showed a total leukocyte count of 8,300/µL with 50% neutrophils and 23% lymphocytes, hemoglobin 14.7 g/dL, hematocrit 44.9%, and platelet count 114,000/ µL. C-reactive protein (CRP) was less than 0.3 mg/dL. Initial chest radiograph showed total hazziness of both lungs which was characteristic of hyaline membrane disease. To clarify the mode of CMV infection acquisition, genotyping and nucleotide sequencing were performed on blood, urine and breast milk specimens isolated from infant and mother as previous described manner 9) . Approximately 296 bp size human CMV gB gene amplification products were detected from infantile blood, infantile urine, and maternal breast milk (Fig. 1) . Restriction patterns on subsequent analysis of the viral UL55 region with restriction enzyme Hinf I and Rsa I revealed CMV gene products on both infant and maternal samples to be identical with Towne strain which is gB type 1 (Fig. 2) . The alignments of the sequences were carried out on the gB PCR products of infantile blood, infantile urine, and maternal breast milk and the sequence data were compared with each other as well as with the published sequences of the GenBank database using the BLAST software. The nucleotide sequence alignments of the infantile blood and urine resulted to be completely identical with the maternal breast milk, and the sequences of the infantile blood (GenBank CMV-TOWNE GGAACTCGAACGTTTGGCCAACCGCTCCAGTCTGAATCTTACTCATAATAGAACCAAAAG 60 CMV-Merlin ******G****************************************G************ 60 Infant blood ******G****************************************G************ 60 Infant urine ******G****************************************G************ 60 Breast milk ******G****************************************G************ 60 CMV-TOWNE AAGTACAGATGGCAACAATGCAACTCATTTATCCAACATGGAGTCGGTGCACAATCTGGT 120 CMV-Merlin **********************************G*******A***************** 120 Infant blood **********************************G*******A***************** 120 Infant urine **********************************G*******A***************** 120 Breast milk **********************************G*******A***************** 120 CMV-TOWNE CTACGCCCAGCTGCAGTTCACCTATGACACGTTGCGCGGTTACATCAACCGGGCGCTGGC 180 CMV-Merlin ************************************************************ 180 Infant blood ************************************************************ 180 Infant urine ************************************************************ 180 Breast milk ************************************************************ 180 CMV-TOWNE GCAAATCGCAGAAGCCTGGTGTGTGGATCAACGGCGCACCCTAGAGGTCTTCAAGGAACT 240 CMV-Merlin *********G****************************G************T*G****** 240 Infant blood *********G****************************G************T*G****** 240 Infant urine *********G****************************G************T*G****** 240 Breast milk *********G****************************G************T*G****** 240 CMV-TOWNE TAGCAAGATCAACCCGTCAGCTATTCTCTCGGCCATCTACAACAAACCGATTGCCGCGCG 300 CMV-Merlin C********************C**************T*********************** 300 Infant blood C********************C**************T*********************** 300 Infant urine C********************C**************T*********************** 300 Breast milk C********************C**************T*********************** 300 CMV-TOWNE TTTC 304 CMV-Merlin **** 304 Infant blood **** 304 Infant urine **** 304 Breast milk **** 304 .
In different studies, postnatal transmission rates of CMV to term and preterm infants varied between 10% and 60% 4, 6, [12] [13] [14] .
It has been indicated that CMV DNA in breast milk is the consequence of locally restricted virus reactivation in the breast rather than the consequence of a systemic virus reactivation 12) . CMV secretion into milk may begin in the [16] [17] [18] . A study of distribution of CMV gB genotypes in hematopoietic stem cell transplant recipients in Korea showed gB1 predominance, but no significant association between the genotypes and diseases was found 9) . It has been demonstrated that the patients who survived CMV infections after bone marrow transplantation were more likely to excrete strains with the gB1 genotype than were patients who died 16) . The presence of gB2 in blood isolates was potentially associated with a greater risk of development of CMV retinitis in patients with AIDS 17) . Although the population in these studies were different, the favorable outcome of the infant in our case might not only be partially due to postnatal mode of CMV infection, but it can also be explained by the gB1 genotype. In recent studies, mixed infection with multiple gB genotypes has been shown to be associated with severe clinical manifestations 19) , a hypothesis that needs additional confirmation. However, gB genotyping is only one of the multiple factors which may influence the outcome of the patient, and we should be cautious in predicting clinical outcomes on the basis of gB genotype alone.
In our case, intrapartum transmission in the birth canal strategies are needed to screen all blood products that are to be transfused to very low birth weight infants.
Based on previous studies, "inactivated" milk, which is treated by freeze-storing or pasteurization, reduces or destroys the viral load [20] [21] [22] . In these studies, it is suggested that various transmission rates despite high rate of CMV DNA in breast milk might be associated with the method of breast milk preservation. However, these studies demonstrate that despite virus inactivation, the transmission of CMV could not be prevented completely. Some other studies have proven that freeze-thawing of breast milk is not a safe intervention to prevent symptomatic CMV infection in preterm infants 23, 24) . More detailed data on the dynamics of CMV reactivation are needed to settle the debate on whether and how to inactivate CMV in breast milk.
Breast milk feeding is beneficial for the infant, especially in the extremely low birth weight infants. However, as most immature preterm infants are at greater risk than term infants to acquire a symptomatic CMV infection, a procedure to prevent CMV transmission through seropositive breast milk should be sought for preterm infants. 
